ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,144.13
-0.04%
Dow Jones
37,815.92
-1.49%
Gold vs US Dollar
2,285.785
-2.05%
Brent Oil
85.93
-1.55%
Bitcoin
60,099.01
-5.86%
Pepperstone
Advertisement
Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Royalty Pharma PLC (RPRX)

  7. Royalty Pharma PLC (RPRX) News

Royalty Pharma (RPRX)

Royalty Pharma PLC
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:RPRX
DateTimeSourceHeadlineSymbolCompany
19/04/202413:15GlobeNewswire Inc.Royalty Pharma to Announce First Quarter 2024 Financial Results on May 9, 2024NASDAQ:RPRXRoyalty Pharma PLC
17/04/202413:15GlobeNewswire Inc.Royalty Pharma Declares Second Quarter 2024 DividendNASDAQ:RPRXRoyalty Pharma PLC
28/02/202421:15GlobeNewswire Inc.Royalty Pharma to Present at TD Cowen’s 44th Annual Health Care ConferenceNASDAQ:RPRXRoyalty Pharma PLC
15/02/202414:05Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:RPRXRoyalty Pharma PLC
15/02/202412:33Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RPRXRoyalty Pharma PLC
15/02/202412:30GlobeNewswire Inc.Royalty Pharma Reports Q4 and Full Year 2023 ResultsNASDAQ:RPRXRoyalty Pharma PLC
06/02/202412:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RPRXRoyalty Pharma PLC
30/01/202421:15GlobeNewswire Inc.Royalty Pharma To Announce Fourth Quarter And Full Year 2023 Financial Results On February 15, 2024NASDAQ:RPRXRoyalty Pharma PLC
19/01/202413:15GlobeNewswire Inc.Royalty Pharma Announces Dividend IncreaseNASDAQ:RPRXRoyalty Pharma PLC
08/01/202412:18Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RPRXRoyalty Pharma PLC
08/01/202412:00GlobeNewswire Inc.Royalty Pharma Highlights Accomplishments and Provides Business Update at 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:RPRXRoyalty Pharma PLC
03/01/202421:31Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RPRXRoyalty Pharma PLC
03/01/202421:30Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:RPRXRoyalty Pharma PLC
29/12/202321:29Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RPRXRoyalty Pharma PLC
27/12/202321:31Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RPRXRoyalty Pharma PLC
27/12/202318:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RPRXRoyalty Pharma PLC
19/12/202321:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RPRXRoyalty Pharma PLC
15/12/202321:31Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RPRXRoyalty Pharma PLC
13/12/202321:47Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:RPRXRoyalty Pharma PLC
27/11/202321:15GlobeNewswire Inc.Royalty Pharma to Present at the Evercore ISI 6th Annual HealthCONx ConferenceNASDAQ:RPRXRoyalty Pharma PLC
16/11/202322:16Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RPRXRoyalty Pharma PLC
16/11/202322:13Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:RPRXRoyalty Pharma PLC
15/11/202300:35Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RPRXRoyalty Pharma PLC
13/11/202313:10GlobeNewswire Inc.Royalty Pharma and Teva Collaborate to Further Accelerate Olanzapine Lai ProgramNASDAQ:RPRXRoyalty Pharma PLC
13/11/202313:00Business WireTeva and Royalty Pharma Collaborate to Further Accelerate Olanzapine LAI ProgramNASDAQ:RPRXRoyalty Pharma PLC
08/11/202314:04Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:RPRXRoyalty Pharma PLC
08/11/202312:40Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RPRXRoyalty Pharma PLC
08/11/202312:00GlobeNewswire Inc.Royalty Pharma Reports Third Quarter 2023 ResultsNASDAQ:RPRXRoyalty Pharma PLC
19/10/202314:29Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RPRXRoyalty Pharma PLC
19/10/202312:59GlobeNewswire Inc.Royalty Pharma Announces Agreement to Purchase Up to $1.5 Billion of PTC Therapeutics’ Royalty on EvrysdiNASDAQ:RPRXRoyalty Pharma PLC
 Showing the most relevant articles for your search:NASDAQ:RPRX

Your Recent History

LSE
MIN
Minoan
LSE
SYME
Supply@me Capital
LSE
MTRO
Metro Bank
LSE
SOLG
Solgold
LSE
PFC
Petrofac
LSE
GGP
Greatland Gold
LSE
VAST
Vast Resources
LSE
POS
Plexus
LSE
DELT
Deltic Energy
LSE
TERN
Tern
LSE
AAZ
Anglo Asian Mining
LSE
BOO
Boohoo
LSE
SCLP
Scancell
LSE
CARD
Card Factory
LSE
BIRD
Blackbird
LSE
TRP
Tower Resources
Delayed Upgrade Clock
    ADVFN Logo

    United Kingdom
    Company
    Business
    Popular
    Get The App

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved